Position in SRRK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,359,940
+$6,626,640 QoQ
Shares Held
149,714
+799.3% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Derivatives in SRRK
reported options exposure · as of Jun 30, 2022CallValue
$137,250
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Balyasny Asset Management L.P. holds $2,162,672,955 across 176 Biotechnology names. SRRK ranks #77 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
2,779,445 | $146,532,340 | |
| 2 | ERAS |
Erasca, Inc.
|
5,143,985 | $83,229,677 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
3,826,659 | $80,053,706 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
1,917,501 | $77,141,065 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,362,752 | $76,981,860 | |
| 6 | CYTK |
Cytokinetics Inc
|
992,545 | $65,418,640 | |
| 7 | DAWN |
Day One Biopharmaceuticals, Inc.
|
2,625,235 | $56,285,038 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,827,513 | $55,345,837 |
All Filings in SRRK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,359,940 | 149,714 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $733,300 | 16,647 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,806,099 | 558,703 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $33,062,161 | 933,432 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $3,270,330 | 408,281 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,049,429 | 366,078 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,985,009 | 562,219 | Shares | Sole | 2024-05-13 | |
| 2023-03-31 | $115,664 | 14,458 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $227,461 | 25,134 | Shares | Other | 2023-02-14 | |
| 2022-06-30 | $137,250 | 25,000 | Call | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||